KRAS and non-small cell lung carcinoma: In mutant KRAS-driven NSCLC cells, LKB1 loss resulted in increased redox stress, increased levels of intracellular reactive oxygen species, and decreased ATP synthesis, NADPH/NADP+ ratio, and glutathione levels (56).